Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina

Jump to navigation Jump to search


Resident
Survival
Guide

Acute Coronary Syndrome Main Page

Unstable angina / NSTEMI Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Unstable Angina
Non-ST Elevation Myocardial Infarction

Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders

Epidemiology and Demographics

Risk Stratification

Natural History, Complications and Prognosis

Special Groups

Women
Heart Failure and Cardiogenic Shock
Perioperative NSTE-ACS Related to Noncardiac Surgery
Stress (Takotsubo) Cardiomyopathy
Diabetes Mellitus
Post CABG Patients
Older Adults
Chronic Kidney Disease
Angiographically Normal Coronary Arteries
Variant (Prinzmetal's) Angina
Substance Abuse
Cardiovascular "Syndrome X"

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Blood Studies
Biomarkers

Electrocardiogram

Chest X Ray

Echocardiography

Coronary Angiography

Treatment

Primary Prevention

Immediate Management

Anti-Ischemic and Analgesic Therapy

Cholesterol Management

Antitplatelet Therapy

Antiplatelet therapy recommendations
Aspirin
Thienopyridines
Glycoprotein IIb/IIIa Inhibitor

Anticoagulant Therapy

Additional Management Considerations for Antiplatelet and Anticoagulant Therapy

Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS

Mechanical Reperfusion

Initial Conservative Versus Initial Invasive Strategies
PCI
CABG

Complications of Bleeding and Transfusion

Discharge Care

Medical Regimen
Post-Discharge Follow-Up
Cardiac Rehabilitation

Long-Term Medical Therapy and Secondary Prevention

ICD implantation within 40 days of myocardial infarction

ICD within 90 days of revascularization

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina

CDC onUnstable angina / non ST elevation myocardial infarction and prinzmetal's angina

Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina in the news

Blogs on Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina

to Hospitals Treating Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina

Risk calculators and risk factors for Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Smita Kohli, M.D.

Synonyms and keywords: Prinzmetal's angina, variant angina, angina inversa

Overview

Prinzmetal's angina, also known as variant angina or angina inversa, is chest pain at rest that occurs in periodic cycles. It is unrelated to exertion although can occur with exertion. Prinzmetal's angina is caused by vasospasm, a narrowing of the coronary arteries caused by contraction of the smooth muscle tissue in the vessel walls rather than fixed narrowings of the coronary arteries due to atherosclerosis. Attacks can be precipitated by an emotional stress, hyperventilation, exercise, or exposure to cold. A circadian variation in the episodes of angina is most often present, with most attacks occurring in the early morning. It is characterized by transient ST-segment elevation that spontaneously resolves or resolves with nitroglycerin use without progression to MI. The majority of patients have normal exercise tolerance, and stress testing may be negative. Because the anginal discomfort usually occurs at rest without a precipitating cause, it may simulate UA/NSTEMI secondary to coronary atherosclerosis.

Mechanism

  • The precise mechanisms have not been established, but a systemic alteration in nitric oxide production or an imbalance between endothelium-derived relaxing and contracting factors may be causative.
  • Enhanced phospholipase C (PLC) activity has also been documented.
  • An inflammatory etiology is supported by the finding of elevated levels of serum hs-CRP in these patients.
  • Histological findings in patients undergoing coronary atherectomy suggest that repetitive coronary vasospasm may provoke vascular injury and lead to the formation of neointimal hyperplasia at the initial site of spasm, leading to rapid progression of coronary stenosis in some patients.

Diagnosis

  • The key to the diagnosis of variant angina is the documentation of ST-segment elevation in a patient during transient chest discomfort and that resolves with the relief of chest discomfort.
  • Continuous 12-lead ECG monitoring can be performed for this purpose in-hospital or as an outpatient.
  • Typically, NTG is extremely effective in relieving the spasm.
  • In variant angina, the spasm can be superimposed on severe or non-severe coronary stenosis or supervene in an angiographically normal coronary artery segment. Hence, coronary angiography is usually part of the workup of these patients and can help guide the treatment.
  • Provocative tests can be used to precipitate coronary artery spasm when the diagnosis is suspected but not objectively documented.
  • Nitrates and calcium channel blockers should be withdrawn well before provocative testing. These tests are more often used during coronary angiography.
  • Acetylcholine and methacholine are now predominantly used for pharmacological provocative tests.
  • Although the spasm is usually promptly relieved with NTG administered intracoronarily or intravenously, it may at times be refractory to therapy with NTG and can lead to MI and even death. For these reasons, provocative tests are now rarely used.

Treatment

  • Calcium antagonists have proved extremely effective in preventing the coronary artery spasm of variant angina and they should ordinarily be prescribed in maximally tolerated doses on a long-term basis. Because nitrates and calcium channel blockers act through different mechanisms, they may have additive vasodilatory effect.
  • Beta-blockers have theoretical adverse potential, and their clinical effect is controversial.
  • Alpha-receptor blockers have been reported to be of benefit.
  • Nicorandil, a vasodilator that influences coronary arterial tone by acting through potassium channel activation, appears to be effective for the treatment of vasospastic angina.
  • Aspirin, helpful in unstable angina, may theoretically increase the severity of ischemic episodes in patients with variant angina because it inhibits biosynthesis of the naturally occurring coronary vasodilator prostacyclin.
  • Revascularization may be helpful in patients with variant angina and discrete, proximal fixed obstructive lesions.
  • Patients who have experienced ischemia-associated ventricular fibrillation who continue to manifest ischemia despite maximal medical treatment should receive an implantable cardioverter-defibrillator.

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes (DO NOT EDIT) [1]

Medical Regimen and Use of Medications at Discharge

Class I
"1.CCBs alone or in combination with long-acting nitrates are useful to treat and reduce the frequency of vasospastic angina.(Level of Evidence: B)"
"2.Treatment with HMG-CoA reductase inhibitor, cessation of tobacco use, and additional atherosclerosis risk factor modification and are useful in patients with vasospastic angina. (Level of Evidence: B)"
"3.Coronary angiography (invasive or noninvasive) is recommended in patients with episodic chest pain accompanied by transient ST-elevation to rule out severe obstructive CAD. (Level of Evidence: C)"
Class IIb
"1. Provocative testing during invasive coronary angiography†† may be considered in patients with suspected vasospastic angina when clinical criteria and noninvasive testing fail to establish the diagnosis (Level of Evidence: B)"

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non -ST-Elevation Myocardial Infarction (DO NOT EDIT)[2][3]

Variant (Prinzmetal's) Angina (DO NOT EDIT)[2][3]

Class I
"1. Diagnostic investigation is indicated in patients with a clinical picture suggestive of coronary spasm, with investigation for the presence of transient myocardial ischemia and ST-segment elevation during chest pain. (Level of Evidence: A)"
"2. Coronary angiography is recommended in patients with episodic chest pain accompanied by transient ST segment elevation. (Level of Evidence: B)"
"3. Treatment with nitrates and calcium channel blockers is recommended in patients with variant angina whose coronary angiogram shows no or non obstructive coronary artery lesions. Risk factor modification is recommended, with patients with atherosclerotic lesions considered to be at higher risk. (Level of Evidence: B)"
Class III
"1. Provocative testing is not recommended in patients with variant angina and high-grade obstructive stenosis on coronary angiography. (Level of Evidence: B)"
Class IIb
"1. Percutaneous coronary intervention may be considered in patients with chest pain and transient ST segment elevation and a significant coronary artery stenosis. (Level of Evidence: B)"
"2. Provocative testing may be considered in patients with no significant angiographic CAD and no documentation of transient ST segment elevation when clinically relevant symptoms possibly explained by coronary artery spasm are present. (Level of Evidence: C)"

References

  1. Ezra A. Amsterdam, MD, FACC; Nanette K. Wenger, MD et al.2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC. September 2014 (ahead of print)
  2. 2.0 2.1 Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE; et al. (2011). "2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 123 (18): e426–579. doi:10.1161/CIR.0b013e318212bb8b. PMID 21444888.
  3. 3.0 3.1 Anderson JL, Adams CD, Antman EM; et al. (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". JACC. 50 (7): e1–e157. PMID 17692738. Text "doi:10.1016/j.jacc.2007.02.013 " ignored (help); Unknown parameter |month= ignored (help)

Template:WH Template:WS